Saltar al contenido
Merck

PDI regulates seizure activity via NMDA receptor redox in rats.

Scientific reports (2017-02-16)
Ji Yang Kim, Ah-Rhem Ko, Hye-Won Hyun, Su-Ji Min, Ji-Eun Kim
RESUMEN

Redox modulation of cysteine residues is one of the post-translational modifications of N-methyl-D-aspartate receptor (NMDAR). Protein disulfide isomerases (PDI), an endoplasmic reticulum (ER) chaperone, plays a crucial role in catalyzing disulfide bond formation, reduction, and isomerization. In the present study, we found that PDI bound to NMDAR in the normal hippocampus, and that this binding was increased in chronic epileptic rats. In vitro thiol reductase assay revealed that PDI increased the amount of thiols on full-length recombinant NR1 protein. PDI siRNA, 5-5'-dithio-bis(2-nitrobenzoic acid) (DTNB), bacitracin and PDI antibody reduced seizure susceptibility in response to pilocarpine. In addition, PDI knockdown effectively ameliorated spontaneous seizure activity in chronic epileptic rats. Anticonvulsive effects of PDI siRNA were correlated to the reduction of the amount of free- and nitrosothiols on NMDAR, accompanied by the inhibition of PDI activity. However, PDI knockdown did not lead to alteration in basal neurotransmission or ER stress under physiological condition. These findings provide mechanistic insight into sulfhydration of disulfide bonds on NMDAR by PDI, and suggest that PDI may represent a target of potential therapeutics for epilepsy, which avoids a possible side effect on physiological receptor functionality.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-β-actina monoclonal antibody produced in mouse, clone AC-74, ascites fluid
Sigma-Aldrich
Anticuerpo anti-proteína gliofibrilar ácida (GFAP), serum, Chemicon®
Sigma-Aldrich
Anticuerpo anti-NMDAR2B, Chemicon®, from rabbit
Sigma-Aldrich
Anti-NMDAR1 Antibody, rabbit monoclonal, culture supernatant, clone 1.17.2.6, Chemicon®
Sigma-Aldrich
Anti-Muscarinic Acetylcholine Receptor m1 Antibody, Chemicon®, from rabbit